Assessment of Hepatic Fibrosis by Shear Wave Elastography in Patients With Liver Malignancy: A Prospective Single-center Study

Sun Yat-sen University121 enrolled

Overview

To evaluate the diagnostic performance of two-dimensional shear-wave elastography (SWE) for staging hepatic fibrosis in the background liver parenchyma in patients with liver tumors before hepatic resection, using resected tissue pathology as a reference standard.

Study Type

OBSERVATIONAL

Enrollment

121

Conditions

Liver Tumor Hepatic Fibrosis

Interventions

two-dimensional shear-wave elastography (SWE)OTHER

performa two-dimensional shear-wave elastography (SWE) for staging hepatic fibrosis in the background liver parenchyma in patients with liver tumors before hepatic resection

Eligibility

Sex: ALLMin age: 18 YearsMax age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: * (i) patients with a solid focal liver lesion that was pathologically proven or diagnosed by imaging methods such as conventional US, CT or MR imaging; (ii) patients scheduled to undergo a hepatectomy; (iii) patients with a lesion ≥1.0 cm in diameter. Exclusion Criteria: * (i) patients with a history of chemotherapy; (ii) patients unable to properly hold their breath.

Outcomes

Primary Outcomes

Stage of hepatic fibrosis

compare the stage of hepatic fibrosis between SWE test with specimens after surgery

Time frame: within the first 7 days after surgery

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.